Lantheus Holdings Inc. (0L8)
XDUS
Real-time Data
06:00 AM
Day's Range
88.4052 wk Range
43.53Overview - 0L8 - Lantheus Holdings Inc.
Key Statistics
Valuation
Enterprise Value
260.31M
P/E (Trailing)
‪25.23‬
Price / Book
‪4.33‬
EV / EBITDA
‪0.63‬
Profitability
Gross Margin
‪62.30%‬
Profit Margin
‪61.10%‬
Operating Margin
‪21.63%‬
Return on Assets
‪10.48%‬
Return on Equity
‪21.43%‬
Ownership
Shares Outstanding
65.26M
Price stats
50-Day Avg
‪87.57‬
200-Day Avg
‪75.83‬
Peers - 0L8 - Lantheus Holdings Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XDUS.
- 0L8XDUSLantheus Holdings Inc.+49.94%52-week change25.23P/E (Trailing)‪61.10%‬Profit Margin
- 20MPXDUSThe More Life Company Corp.+77.14%52-week change-3.50P/E (Trailing)—Profit Margin
- NGQ1XDUSMedicure Inc.+74.79%52-week change-3.53P/E (Trailing)‪40.71%‬Profit Margin
- PA8XDUSPaion AG+71.80%52-week change-0.76P/E (Trailing)‪94.10%‬Profit Margin
- I76XDUSIronwood Pharmaceuticals, Inc. Class A Common Stock+59.06%52-week change21.33P/E (Trailing)—Profit Margin
- HLSXDUSAIC Mines Limited+58.86%52-week change—P/E (Trailing)—Profit Margin
- 2DTXDUSAmneal Pharmaceuticals, Inc.+52.03%52-week change74.78P/E (Trailing)‪36.87%‬Profit Margin
Profile Summary - 0L8 - Lantheus Holdings Inc.
About
Lantheus Holdings Inc. is a radiopharmaceutical-focused healthcare company that develops, manufactures, and commercializes diagnostic and therapeutic products used to help clinicians detect, localize, and monitor disease. Its portfolio centers on precision diagnostics and nuclear medicine solutions for oncology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
